It has been shown, however, that genetic deletions [27], promoter hypermethylation [28], and microRNA-mediated suppression [29] can contribute to HMGB1 loss, and that HMGB1 deficiency can affect both tumor cell biology and tumor microenvironment. This evidence concerns the gene HMGB1 and neoplasm.